Senate investigations panel to probe Mylan's EpiPen pricing
By REUTERS
Published: SEPTEMBER 7, 2016 22:34
The US Senate's permanent subcommittee on investigations has decided to look into Mylan Pharmaceuticals' pricing of the EpiPen, according to a press release issued on Wednesday.The release described the probe as a "preliminary inquiry."